Christopher Mutz
HEAD OF RARE DISEASE · ANI PHARMACEUTICALS INC
- 2024
- Mar 13, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher Mutz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nikhil Lalwani - $5.05M in ANIP purchases and sales in the last 12 months
- Patrick D. Walsh - $2.32M in ANIP purchases and sales in the last 12 months
- Stephen P. Carey - $1.99M in ANIP purchases and sales in the last 12 months
- Chad Gassert - $1.31M in ANIP purchases and sales in the last 12 months
- Krista Davis - $785K in ANIP purchases and sales in the last 12 months
- Ori Gutwerg - $621K in ANIP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher Mutz?
Christopher Mutz is a corporate insider, tracked as HEAD OF RARE DISEASE of ANI PHARMACEUTICALS INC (ANIP). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Christopher Mutz last file a Form 4?
The most recent primary Form 4 on record is dated 13 March 2026, one of 9 filings going back to 2024.
Has Christopher Mutz been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($2.25M) across all tracked filings.
